Alvino Rebecca T, Caughell Carolyn M
AORN J. 2021 Feb;113(2):147-164. doi: 10.1002/aorn.13301.
The evolution of SARS-CoV-2 from a zoonotic virus to a novel human pathogen resulted in the coronavirus disease 2019 (COVID-19) global pandemic. Health care delivery and infection prevention and control recommendations continue to evolve to protect the safety of health care personnel, patients, and visitors while researchers and policymakers learn more about SARS-CoV-2 and COVID-19. The perioperative setting is unique in that it exposes clinicians and personnel to increased risks through the invasive nature of surgical care. Using the Centers for Disease Control and Prevention's Hierarchy of Controls as a model, this article presents risk mitigation strategies for preventing the transmission of COVID-19 in the perioperative environment. The goals are to identify and eliminate potential exposure to SARS-CoV-2 when surgery is necessary for patients who are suspected or confirmed to have COVID-19 or who have an unknown infection status.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)从一种人畜共患病毒演变为一种新型人类病原体,导致了2019冠状病毒病(COVID-19)全球大流行。在研究人员和政策制定者进一步了解SARS-CoV-2和COVID-19的同时,医疗服务以及感染预防与控制建议也在不断演变,以保护医护人员、患者和访客的安全。围手术期环境具有独特性,因为手术护理的侵入性使临床医生和工作人员面临更高的风险。本文以美国疾病控制与预防中心的控制层级为模型,提出了在围手术期环境中预防COVID-19传播的风险缓解策略。目标是在为疑似或确诊感染COVID-19或感染状况不明的患者进行必要手术时,识别并消除潜在的SARS-CoV-2暴露风险。